AwardTape · Defense awards · Medical · Diagnostics and lab supplies · N3239826P0015
N3239826P0015: $155K purchase order to Maxim Biomedical, Inc
Maxim Biomedical, Inc holds a purchase order from Department of the Navy with $155K obligated since Oct 2023, against a ceiling of $155K. Latest action May 15, 2026.
This requirement is for a multiplex blind-spot lfi supply kit.
| PIID | N3239826P0015 |
|---|---|
| Type | purchase order |
| Company | Maxim Biomedical, Inc |
| Agency | Department of the Navy |
| Contracting office | NAVAL MEDICAL RESEARCH CENTER |
| Category | Medical · Diagnostics and lab supplies |
| PSC | 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS |
| NAICS | 325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING |
| Obligated since Oct 2023 | $155K |
| Total obligated (lifetime) | $155K |
| Ceiling (base and all options) | $155K |
| Base date | May 15, 2026 |
| Latest action | May 15, 2026 |
| End date | May 18, 2027 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Competed under simplified acquisition |
| Place of performance | MD |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial